MYC and mucopolysaccharidosis type 3D: In our initial study, we showed that myc-rhGNS can be successfully produced from Chinese hamster ovary (CHO) cells, that the myc-rhGNS produced from CHO cells has appropriate post-translational modifications, is active in vitro, and has efficacy in treating MPS IIID patient fibroblasts.